#protein folding
Sep 2026
Abstract A006: Identification of a novel, safety-engineered ADC directed against FGFR4 for the treatment of Rhabdomyosarcoma
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children and young adults. While low risk disease has a 90% survival probability, metastatic RMS has a dismal prognosis. Treatment options include chemotherapy and local therapy (surgery, radiotherapy) but suffer from serious long-term side effects. The...
C. Steinkühler, Mirko Brunetti, Cristina Maria Depalma et al.
· Cancer Research · 0 citations